OTC Markets OTCPK - Delayed Quote USD
Clarity Pharmaceuticals Ltd (CLRPF)
At close: November 7 at 3:00 PM EST
Breakdown
6/30/2024
6/30/2023
6/30/2022
Total Assets
154,629.2070
76,896.4060
99,821.9430
Total Liabilities Net Minority Interest
8,331.7570
7,720.7380
7,585.4090
Total Equity Gross Minority Interest
146,297.4500
69,175.6680
92,236.5340
Total Capitalization
146,297.4500
69,175.6680
92,236.5340
Common Stock Equity
146,297.4500
69,175.6680
92,236.5340
Net Tangible Assets
146,297.4500
69,175.6680
92,236.5340
Working Capital
145,972.4880
69,135.8810
92,043.9230
Invested Capital
146,297.4500
69,175.6680
92,236.5340
Tangible Book Value
146,297.4500
69,175.6680
92,236.5340
Share Issued
311,645.8970
132,525.7260
258,739.8210
Ordinary Shares Number
311,645.8970
132,525.7260
258,739.8210
6/30/2022 - 8/15/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TLPPF Telix Pharmaceuticals Limited
15.25
+1.33%
RAPP Rapport Therapeutics, Inc.
26.90
+2.87%
EVAX Evaxion Biotech A/S
2.6200
0.00%
TLX.AX Telix Pharmaceuticals Limited
22.99
+0.57%
TFFP TFF Pharmaceuticals, Inc.
1.6300
-1.21%
RLFTF Relief Therapeutics Holding SA
6.62
-0.51%
ACIU AC Immune SA
3.2700
+5.83%
PCVX Vaxcyte, Inc.
102.70
-1.32%
CSL.AX CSL Limited
285.29
+0.67%
MDXG MiMedx Group, Inc.
7.44
-0.80%